Moreover, ADMA has a negative impact on the endothelial-NO synthase 3 (NOS3) based on the dysfunction of endothelial cells associated with a variety of diseases including coronary artery disease, diabetes mellitus, and hypertension. This evidence concerns the gene NOS3 and coronary artery disorder.